Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 3/20 | 0.44 |
| ▸ | CES1 | P23141 | 3/20 | 0.44 |
| ▸ | LMNA | P02545 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | FAAH | O00519 | 1/20 | 0.43 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 2/20 | 0.42 |
| ▸ | PPARD | Q03181 | 2/20 | 0.42 |
| ▸ | PPARA | Q07869 | 2/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.42 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.42 |
| ▸ | TLR2 | O60603 | 1/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7269030 | 0.88 | CES2 (0.39) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL9223157 | 0.83 | CA1 (0.50) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL7923708 | 0.83 | FFAR4 (0.45) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL2505302 | 0.83 | CA1 (0.50) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL10967910 | 0.80 | CES2 (0.44) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL20500817 | 0.80 | CES2 (0.44) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL583014 | 0.79 | CES2 (0.48) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL8089273 | 0.79 | CES2 (0.48) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL29084742 | 0.79 | CES2 (0.48) | CES2CES1LMNAMEN1FAAH | |
| SCHEMBL5506970 | 0.77 | CES2 (0.46) | CES2CES1LMNAMEN1FAAH |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100298432-A1 | Cosmetic Compositions Containing Esters of 2-Butyloctanol | COGNIS IP MANAGEMENT GMBH (DE) | 2010-11-25 | — | — | US | claimed |
| EP-2051781-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS OF 2-BUTYLOCTANOL | Cognis IP Management GmbH (DE) | 2009-04-29 | — | — | EP | claimed |
| WO-2008019794-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS OF 2-BUTYLOCTANOL | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-21 | — | — | WO | claimed |
| EP-2071010-B1 | GREASE | IDEMITSU KOSAN CO (JP) | 2019-08-07 | — | — | EP | disclosed |
| US-8703678-B2 | Grease | IDEMITSU KOSAN CO., LTD. (JP) | 2014-04-22 | — | — | US | disclosed |
| US-20100298432-A1 | Cosmetic Compositions Containing Esters of 2-Butyloctanol | COGNIS IP MANAGEMENT GMBH (DE) | 2010-11-25 | — | — | US | disclosed |
| US-20100035779-A1 | GREASE | IDEMITSU KOSAN CO., LTD (JP) | 2010-02-11 | — | — | US | disclosed |
| EP-1503763-B1 | THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH | CRAGMONT PHARMACEUTICALS LLC (US) | 2009-12-02 | — | — | EP | disclosed |
| EP-2071010-A1 | GREASE | Idemitsu Kosan Co., Ltd. (JP) | 2009-06-17 | — | — | EP | disclosed |
| EP-2051781-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS OF 2-BUTYLOCTANOL | Cognis IP Management GmbH (DE) | 2009-04-29 | — | — | EP | disclosed |
| WO-2008019794-A1 | COSMETIC COMPOSITIONS CONTAINING ESTERS OF 2-BUTYLOCTANOL | COGNIS IP MANAGEMENT GMBH (DE) | 2008-02-21 | — | — | WO | disclosed |
| EP-1503763-A1 | THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH | Cragmont Pharmaceuticals, LLC (US) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003092697-A1 | THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH | CRAGMONT PHARMACEUTICALS, LLC (US) | 2003-11-13 | — | — | WO | disclosed |